Literature DB >> 29775745

Analysis of neurotrophic and antioxidant factors related to midbrain dopamine neuronal loss and brain inflammation in the cerebrospinal fluid of the elderly.

Angel Martin-de-Pablos1, Antonio Córdoba-Fernández2, Emilio Fernández-Espejo3.   

Abstract

Midbrain dopamine neuronal loss and neuroinflammation are two phenomena that are associated with brain senescence. Neurotrophic factor changes and oxidative stress could subserve these phenomena. Aging-related brain changes can be well monitored through the cerebrospinal fluid (CSF). The objective was to analyze neurotrophic and oxidative parameters that could be related to midbrain dopamine neuronal loss or brain inflammation in the CSF of elderly subjects: 1) levels of the dopaminotrophic factors BDNF, GDNF, persephin, and neurturin, 2) levels of the proinflammatory factors TGFβ1 and TGFβ2; 3) activity of main antioxidant enzymes (catalases, glutathione-peroxidase, glutathione-reductase, glutathione-S-transferases, peroxirredoxins, and superoxide-dismutases), 4) ferritin content, antioxidant protein which reduces reactive free iron, and 5) antioxidant potential of the cerebrospinal fluid. ELISA and PAO tests were used. Subjects were also evaluated clinically, and the group of old subjects with mild cognitive impairment was studied separately. The findings indicate that normal elderly CSF is devoid of changes in either dopaminotrophic or proinflammatory factors. The antioxidant efficacy is slightly reduced with normal aging, through a reduction of glutathione-S-transferase activity in people older than 74 years (p < 0.05). However old people with mild cognitive impairment show reduced BDNF levels, and stronger signs of oxidative stress such as low antioxidant potential and glutathione-S-transferase activity (p < 0.05). To sum up, the present study demonstrates that, in CSF of normal senescence, dopaminotrophic factors and proinflammatory TGF-family ligands are not affected, and antioxidant efficacy is slightly reduced. CSF of elderly subjects with mild cognitive impairment shows more oxidative and trophic changes that are characterized by reduction of BDNF content, glutathione-S-transferase activity, and antioxidant potential.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Antioxidant; BDNF; CSF; Ferritin; Glutathione-S-transferase; Trophic factor

Mesh:

Substances:

Year:  2018        PMID: 29775745     DOI: 10.1016/j.exger.2018.05.009

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  5 in total

1.  Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson's Disease.

Authors:  Emilio Fernández-Espejo; Fernando Rodríguez de Fonseca; Ana Luisa Gavito; Antonio Córdoba-Fernández; José Chacón; Ángel Martín de Pablos
Journal:  Antioxidants (Basel)       Date:  2022-05-30

2.  Ganoderma tsugae prevents cognitive impairment and attenuates oxidative damage in d-galactose-induced aging in the rat brain.

Authors:  Hui-Chuan Kuo; Sih-Yu Tong; Ming-Wei Chao; Chia-Yi Tseng
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

Review 3.  The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence.

Authors:  Angelica Varesi; Salvatore Chirumbolo; Lucrezia Irene Maria Campagnoli; Elisa Pierella; Gaia Bavestrello Piccini; Adelaide Carrara; Giovanni Ricevuti; Catia Scassellati; Cristian Bonvicini; Alessia Pascale
Journal:  Antioxidants (Basel)       Date:  2022-06-22

4.  Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ´s disease.

Authors:  Emilio Fernández-Espejo; Ana L Gavito; Juan Suárez; Eduardo Tolosa; Dolores Vilas; Iban Aldecoa; Joan Berenguer; Antonio Córdoba-Fernández; Fátima Damas-Hermoso; Fernando Rodríguez de Fonseca
Journal:  Clin Park Relat Disord       Date:  2022-08-28

5.  Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson's Disease.

Authors:  Emilio Fernández-Espejo; Fernando Rodríguez de Fonseca; Juan Suárez; Eduardo Tolosa; Dolores Vilas; Iban Aldecoa; Joan Berenguer; Fátima Damas-Hermoso
Journal:  Antioxidants (Basel)       Date:  2021-05-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.